Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 12, 2005. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details specific share acquisitions by four individuals under the Company's ShareReward Plan on December 9, 2005, at a price of GBP14.40 per share:
- Mr J S Heslop: Acquired 9 shares (personal contribution) and 9 shares (Company matching contribution).
- Mr R Bondy: Acquired 9 shares (personal contribution) and 9 shares (Company matching contribution).
- Mr A P Witty: Acquired 9 shares (personal contribution) and 9 shares (Company matching contribution).
- Mrs J V Younger: Acquired 9 shares (personal contribution) and 9 shares (Company matching contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the aforementioned share transactions in accordance with Disclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b).
Investor Verification Points
- Verify the share price of GBP14.40 per Ordinary Share on December 9, 2005.
- Confirm the terms of the ShareReward Plan entered into on October 5, 2001.
- Review the total number of shares held by the named individuals post-transaction.